nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Liver disorder—Ezetimibe—atherosclerosis	0.0126	0.0129	CcSEcCtD
Cefuroxime—Liver disorder—Simvastatin—atherosclerosis	0.012	0.0123	CcSEcCtD
Cefuroxime—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.0109	0.0111	CcSEcCtD
Cefuroxime—Liver disorder—Pravastatin—atherosclerosis	0.0108	0.0111	CcSEcCtD
Cefuroxime—Cholestasis—Niacin—atherosclerosis	0.00988	0.0101	CcSEcCtD
Cefuroxime—Cefazolin—PON1—atherosclerosis	0.00934	0.41	CrCbGaD
Cefuroxime—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00873	0.00894	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00857	0.00877	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00817	0.00836	CcSEcCtD
Cefuroxime—Vaginal inflammation—Niacin—atherosclerosis	0.0075	0.00768	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00739	0.00756	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00729	0.00746	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00725	0.00742	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00715	0.00732	CcSEcCtD
Cefuroxime—Vaginal infection—Niacin—atherosclerosis	0.00708	0.00725	CcSEcCtD
Cefuroxime—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00702	0.00719	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00682	0.00698	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00679	0.00694	CcSEcCtD
Cefuroxime—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00657	0.00672	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Niacin—atherosclerosis	0.00623	0.00638	CcSEcCtD
Cefuroxime—Bronchitis—Rosuvastatin—atherosclerosis	0.00622	0.00636	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00616	0.00631	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00613	0.00628	CcSEcCtD
Cefuroxime—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00594	0.00608	CcSEcCtD
Cefuroxime—Cramp muscle—Lovastatin—atherosclerosis	0.00571	0.00584	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00571	0.00584	CcSEcCtD
Cefuroxime—Jaundice—Rosuvastatin—atherosclerosis	0.00562	0.00575	CcSEcCtD
Cefuroxime—Urinary tract infection—Rosuvastatin—atherosclerosis	0.0056	0.00573	CcSEcCtD
Cefuroxime—Cramp muscle—Ezetimibe—atherosclerosis	0.0056	0.00573	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00545	0.00558	CcSEcCtD
Cefuroxime—Eosinophilia—Lovastatin—atherosclerosis	0.00543	0.00555	CcSEcCtD
Cefuroxime—Sinusitis—Rosuvastatin—atherosclerosis	0.00541	0.00553	CcSEcCtD
Cefuroxime—Cramp muscle—Simvastatin—atherosclerosis	0.00534	0.00546	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00534	0.00546	CcSEcCtD
Cefuroxime—Eosinophilia—Ezetimibe—atherosclerosis	0.00532	0.00545	CcSEcCtD
Cefuroxime—Hepatitis—Rosuvastatin—atherosclerosis	0.00518	0.0053	CcSEcCtD
Cefuroxime—Eosinophilia—Simvastatin—atherosclerosis	0.00507	0.00519	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.005	0.00511	CcSEcCtD
Cefuroxime—Bronchitis—Simvastatin—atherosclerosis	0.00493	0.00504	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00484	0.00496	CcSEcCtD
Cefuroxime—Cramp muscle—Pravastatin—atherosclerosis	0.00483	0.00494	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00483	0.00494	CcSEcCtD
Cefuroxime—Infestation—Ezetimibe—atherosclerosis	0.00479	0.0049	CcSEcCtD
Cefuroxime—Infestation NOS—Ezetimibe—atherosclerosis	0.00479	0.0049	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00476	0.00487	CcSEcCtD
Cefuroxime—Urinary tract infection—Lovastatin—atherosclerosis	0.00475	0.00486	CcSEcCtD
Cefuroxime—Jaundice—Ezetimibe—atherosclerosis	0.00467	0.00478	CcSEcCtD
Cefuroxime—Eosinophilia—Pravastatin—atherosclerosis	0.00459	0.00469	CcSEcCtD
Cefuroxime—Sinusitis—Lovastatin—atherosclerosis	0.00458	0.00469	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00453	0.00464	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00453	0.00464	CcSEcCtD
Cefuroxime—Bronchitis—Niacin—atherosclerosis	0.00453	0.00463	CcSEcCtD
Cefuroxime—Sinusitis—Ezetimibe—atherosclerosis	0.0045	0.0046	CcSEcCtD
Cefuroxime—Jaundice—Simvastatin—atherosclerosis	0.00445	0.00456	CcSEcCtD
Cefuroxime—Flatulence—Rosuvastatin—atherosclerosis	0.00444	0.00454	CcSEcCtD
Cefuroxime—Hepatitis—Lovastatin—atherosclerosis	0.00439	0.00449	CcSEcCtD
Cefuroxime—Dysuria—Pravastatin—atherosclerosis	0.00433	0.00443	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00431	0.00441	CcSEcCtD
Cefuroxime—Hepatitis—Ezetimibe—atherosclerosis	0.0043	0.0044	CcSEcCtD
Cefuroxime—Sinusitis—Simvastatin—atherosclerosis	0.00429	0.00439	CcSEcCtD
Cefuroxime—Erythema multiforme—Lovastatin—atherosclerosis	0.00415	0.00424	CcSEcCtD
Cefuroxime—Angioedema—Rosuvastatin—atherosclerosis	0.00412	0.00421	CcSEcCtD
Cefuroxime—Hepatitis—Simvastatin—atherosclerosis	0.0041	0.0042	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.0041	0.00419	CcSEcCtD
Cefuroxime—Stomatitis—Niacin—atherosclerosis	0.00409	0.00419	CcSEcCtD
Cefuroxime—Jaundice—Niacin—atherosclerosis	0.00409	0.00419	CcSEcCtD
Cefuroxime—Erythema multiforme—Ezetimibe—atherosclerosis	0.00407	0.00416	CcSEcCtD
Cefuroxime—Jaundice—Pravastatin—atherosclerosis	0.00403	0.00412	CcSEcCtD
Cefuroxime—Sweating—Niacin—atherosclerosis	0.00402	0.00412	CcSEcCtD
Cefuroxime—Urinary tract infection—Pravastatin—atherosclerosis	0.00402	0.00411	CcSEcCtD
Cefuroxime—Chills—Lovastatin—atherosclerosis	0.00394	0.00403	CcSEcCtD
Cefuroxime—Cough—Rosuvastatin—atherosclerosis	0.00393	0.00402	CcSEcCtD
Cefuroxime—Angiopathy—Ezetimibe—atherosclerosis	0.0039	0.00399	CcSEcCtD
Cefuroxime—Immune system disorder—Ezetimibe—atherosclerosis	0.00389	0.00398	CcSEcCtD
Cefuroxime—Erythema multiforme—Simvastatin—atherosclerosis	0.00388	0.00397	CcSEcCtD
Cefuroxime—Sinusitis—Pravastatin—atherosclerosis	0.00388	0.00397	CcSEcCtD
Cefuroxime—Arthralgia—Rosuvastatin—atherosclerosis	0.00384	0.00392	CcSEcCtD
Cefuroxime—Cefdinir—MPO—atherosclerosis	0.00382	0.168	CrCbGaD
Cefuroxime—Cefaclor—MPO—atherosclerosis	0.00379	0.166	CrCbGaD
Cefuroxime—Haemoglobin—Niacin—atherosclerosis	0.00379	0.00387	CcSEcCtD
Cefuroxime—Haemorrhage—Niacin—atherosclerosis	0.00377	0.00385	CcSEcCtD
Cefuroxime—Hepatitis—Niacin—atherosclerosis	0.00377	0.00385	CcSEcCtD
Cefuroxime—Flatulence—Lovastatin—atherosclerosis	0.00376	0.00385	CcSEcCtD
Cefuroxime—Erythema—Ezetimibe—atherosclerosis	0.00374	0.00383	CcSEcCtD
Cefuroxime—Hepatitis—Pravastatin—atherosclerosis	0.00371	0.0038	CcSEcCtD
Cefuroxime—Flatulence—Ezetimibe—atherosclerosis	0.00369	0.00378	CcSEcCtD
Cefuroxime—Chills—Simvastatin—atherosclerosis	0.00368	0.00377	CcSEcCtD
Cefuroxime—Muscle spasms—Lovastatin—atherosclerosis	0.00367	0.00376	CcSEcCtD
Cefuroxime—Muscle spasms—Ezetimibe—atherosclerosis	0.0036	0.00368	CcSEcCtD
Cefuroxime—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.0036	0.00368	CcSEcCtD
Cefuroxime—Erythema—Simvastatin—atherosclerosis	0.00357	0.00365	CcSEcCtD
Cefuroxime—Flatulence—Simvastatin—atherosclerosis	0.00352	0.0036	CcSEcCtD
Cefuroxime—Erythema multiforme—Pravastatin—atherosclerosis	0.00351	0.00359	CcSEcCtD
Cefuroxime—Angioedema—Lovastatin—atherosclerosis	0.00349	0.00357	CcSEcCtD
Cefuroxime—Muscle spasms—Simvastatin—atherosclerosis	0.00343	0.00351	CcSEcCtD
Cefuroxime—Angioedema—Ezetimibe—atherosclerosis	0.00342	0.0035	CcSEcCtD
Cefuroxime—Angiopathy—Niacin—atherosclerosis	0.00342	0.0035	CcSEcCtD
Cefuroxime—Leukopenia—Lovastatin—atherosclerosis	0.00342	0.0035	CcSEcCtD
Cefuroxime—Chills—Niacin—atherosclerosis	0.00338	0.00346	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00335	0.00343	CcSEcCtD
Cefuroxime—Chills—Pravastatin—atherosclerosis	0.00333	0.00341	CcSEcCtD
Cefuroxime—Palpitations—Ezetimibe—atherosclerosis	0.00331	0.00339	CcSEcCtD
Cefuroxime—Erythema—Niacin—atherosclerosis	0.00328	0.00336	CcSEcCtD
Cefuroxime—Cough—Ezetimibe—atherosclerosis	0.00327	0.00334	CcSEcCtD
Cefuroxime—Angioedema—Simvastatin—atherosclerosis	0.00326	0.00334	CcSEcCtD
Cefuroxime—Arthralgia—Lovastatin—atherosclerosis	0.00325	0.00333	CcSEcCtD
Cefuroxime—Chest pain—Lovastatin—atherosclerosis	0.00325	0.00333	CcSEcCtD
Cefuroxime—Dyspepsia—Rosuvastatin—atherosclerosis	0.00324	0.00331	CcSEcCtD
Cefuroxime—Flatulence—Niacin—atherosclerosis	0.00323	0.00331	CcSEcCtD
Cefuroxime—Leukopenia—Simvastatin—atherosclerosis	0.0032	0.00327	CcSEcCtD
Cefuroxime—Arthralgia—Ezetimibe—atherosclerosis	0.00319	0.00326	CcSEcCtD
Cefuroxime—Chest pain—Ezetimibe—atherosclerosis	0.00319	0.00326	CcSEcCtD
Cefuroxime—Flatulence—Pravastatin—atherosclerosis	0.00318	0.00326	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00317	0.00324	CcSEcCtD
Cefuroxime—Muscle spasms—Niacin—atherosclerosis	0.00315	0.00323	CcSEcCtD
Cefuroxime—Pain—Rosuvastatin—atherosclerosis	0.00314	0.00322	CcSEcCtD
Cefuroxime—Anaphylactic shock—Lovastatin—atherosclerosis	0.00312	0.00319	CcSEcCtD
Cefuroxime—Muscle spasms—Pravastatin—atherosclerosis	0.0031	0.00318	CcSEcCtD
Cefuroxime—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00306	0.00313	CcSEcCtD
Cefuroxime—Thrombocytopenia—Lovastatin—atherosclerosis	0.00305	0.00312	CcSEcCtD
Cefuroxime—Arthralgia—Simvastatin—atherosclerosis	0.00304	0.00311	CcSEcCtD
Cefuroxime—Chest pain—Simvastatin—atherosclerosis	0.00304	0.00311	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00301	0.00308	CcSEcCtD
Cefuroxime—Angioedema—Niacin—atherosclerosis	0.003	0.00307	CcSEcCtD
Cefuroxime—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00299	0.00306	CcSEcCtD
Cefuroxime—Anorexia—Lovastatin—atherosclerosis	0.00297	0.00304	CcSEcCtD
Cefuroxime—Skin disorder—Ezetimibe—atherosclerosis	0.00297	0.00304	CcSEcCtD
Cefuroxime—Angioedema—Pravastatin—atherosclerosis	0.00295	0.00302	CcSEcCtD
Cefuroxime—Leukopenia—Niacin—atherosclerosis	0.00294	0.003	CcSEcCtD
Cefuroxime—Urticaria—Rosuvastatin—atherosclerosis	0.00292	0.00299	CcSEcCtD
Cefuroxime—Anaphylactic shock—Simvastatin—atherosclerosis	0.00291	0.00298	CcSEcCtD
Cefuroxime—Abdominal pain—Rosuvastatin—atherosclerosis	0.00291	0.00297	CcSEcCtD
Cefuroxime—Palpitations—Niacin—atherosclerosis	0.0029	0.00297	CcSEcCtD
Cefuroxime—Leukopenia—Pravastatin—atherosclerosis	0.00289	0.00296	CcSEcCtD
Cefuroxime—Cough—Niacin—atherosclerosis	0.00286	0.00293	CcSEcCtD
Cefuroxime—Thrombocytopenia—Simvastatin—atherosclerosis	0.00285	0.00292	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00284	0.00291	CcSEcCtD
Cefuroxime—Cough—Pravastatin—atherosclerosis	0.00282	0.00288	CcSEcCtD
Cefuroxime—Arthralgia—Niacin—atherosclerosis	0.00279	0.00286	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00278	0.00285	CcSEcCtD
Cefuroxime—Anorexia—Simvastatin—atherosclerosis	0.00278	0.00284	CcSEcCtD
Cefuroxime—Dyspnoea—Lovastatin—atherosclerosis	0.00278	0.00284	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00277	0.00284	CcSEcCtD
Cefuroxime—Arthralgia—Pravastatin—atherosclerosis	0.00275	0.00281	CcSEcCtD
Cefuroxime—Chest pain—Pravastatin—atherosclerosis	0.00275	0.00281	CcSEcCtD
Cefuroxime—Dyspepsia—Lovastatin—atherosclerosis	0.00274	0.00281	CcSEcCtD
Cefuroxime—Dyspnoea—Ezetimibe—atherosclerosis	0.00272	0.00279	CcSEcCtD
Cefuroxime—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00271	0.00277	CcSEcCtD
Cefuroxime—Decreased appetite—Lovastatin—atherosclerosis	0.00271	0.00277	CcSEcCtD
Cefuroxime—Dyspepsia—Ezetimibe—atherosclerosis	0.00269	0.00275	CcSEcCtD
Cefuroxime—Anaphylactic shock—Niacin—atherosclerosis	0.00268	0.00274	CcSEcCtD
Cefuroxime—Pain—Lovastatin—atherosclerosis	0.00266	0.00273	CcSEcCtD
Cefuroxime—Decreased appetite—Ezetimibe—atherosclerosis	0.00266	0.00272	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00266	0.00272	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00264	0.0027	CcSEcCtD
Cefuroxime—Anaphylactic shock—Pravastatin—atherosclerosis	0.00264	0.0027	CcSEcCtD
Cefuroxime—Pain—Ezetimibe—atherosclerosis	0.00261	0.00267	CcSEcCtD
Cefuroxime—Tachycardia—Niacin—atherosclerosis	0.00261	0.00267	CcSEcCtD
Cefuroxime—Pruritus—Rosuvastatin—atherosclerosis	0.0026	0.00266	CcSEcCtD
Cefuroxime—Skin disorder—Niacin—atherosclerosis	0.0026	0.00266	CcSEcCtD
Cefuroxime—Dyspnoea—Simvastatin—atherosclerosis	0.0026	0.00266	CcSEcCtD
Cefuroxime—Hyperhidrosis—Niacin—atherosclerosis	0.00259	0.00265	CcSEcCtD
Cefuroxime—Thrombocytopenia—Pravastatin—atherosclerosis	0.00258	0.00264	CcSEcCtD
Cefuroxime—Dyspepsia—Simvastatin—atherosclerosis	0.00257	0.00263	CcSEcCtD
Cefuroxime—Anorexia—Niacin—atherosclerosis	0.00255	0.00261	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00255	0.00261	CcSEcCtD
Cefuroxime—Hyperhidrosis—Pravastatin—atherosclerosis	0.00255	0.00261	CcSEcCtD
Cefuroxime—Decreased appetite—Simvastatin—atherosclerosis	0.00253	0.00259	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00252	0.00257	CcSEcCtD
Cefuroxime—Diarrhoea—Rosuvastatin—atherosclerosis	0.00252	0.00257	CcSEcCtD
Cefuroxime—Anorexia—Pravastatin—atherosclerosis	0.00251	0.00257	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0025	0.00256	CcSEcCtD
Cefuroxime—Pain—Simvastatin—atherosclerosis	0.00249	0.00255	CcSEcCtD
Cefuroxime—Urticaria—Lovastatin—atherosclerosis	0.00248	0.00253	CcSEcCtD
Cefuroxime—Body temperature increased—Lovastatin—atherosclerosis	0.00246	0.00252	CcSEcCtD
Cefuroxime—Abdominal pain—Lovastatin—atherosclerosis	0.00246	0.00252	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00244	0.0025	CcSEcCtD
Cefuroxime—Dizziness—Rosuvastatin—atherosclerosis	0.00243	0.00249	CcSEcCtD
Cefuroxime—Urticaria—Ezetimibe—atherosclerosis	0.00243	0.00248	CcSEcCtD
Cefuroxime—Body temperature increased—Ezetimibe—atherosclerosis	0.00242	0.00247	CcSEcCtD
Cefuroxime—Abdominal pain—Ezetimibe—atherosclerosis	0.00242	0.00247	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0024	0.00246	CcSEcCtD
Cefuroxime—Dyspnoea—Niacin—atherosclerosis	0.00239	0.00244	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00238	0.00244	CcSEcCtD
Cefuroxime—Somnolence—Niacin—atherosclerosis	0.00238	0.00243	CcSEcCtD
Cefuroxime—Dyspepsia—Niacin—atherosclerosis	0.00236	0.00241	CcSEcCtD
Cefuroxime—Dyspnoea—Pravastatin—atherosclerosis	0.00235	0.0024	CcSEcCtD
Cefuroxime—Decreased appetite—Niacin—atherosclerosis	0.00233	0.00238	CcSEcCtD
Cefuroxime—Dyspepsia—Pravastatin—atherosclerosis	0.00232	0.00237	CcSEcCtD
Cefuroxime—Rash—Rosuvastatin—atherosclerosis	0.00232	0.00237	CcSEcCtD
Cefuroxime—Dermatitis—Rosuvastatin—atherosclerosis	0.00232	0.00237	CcSEcCtD
Cefuroxime—Urticaria—Simvastatin—atherosclerosis	0.00232	0.00237	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Niacin—atherosclerosis	0.00231	0.00236	CcSEcCtD
Cefuroxime—Body temperature increased—Simvastatin—atherosclerosis	0.0023	0.00236	CcSEcCtD
Cefuroxime—Abdominal pain—Simvastatin—atherosclerosis	0.0023	0.00236	CcSEcCtD
Cefuroxime—Headache—Rosuvastatin—atherosclerosis	0.0023	0.00236	CcSEcCtD
Cefuroxime—Hypersensitivity—Lovastatin—atherosclerosis	0.0023	0.00235	CcSEcCtD
Cefuroxime—Decreased appetite—Pravastatin—atherosclerosis	0.00229	0.00234	CcSEcCtD
Cefuroxime—Pain—Niacin—atherosclerosis	0.00229	0.00234	CcSEcCtD
Cefuroxime—Pain—Pravastatin—atherosclerosis	0.00225	0.00231	CcSEcCtD
Cefuroxime—Hypersensitivity—Ezetimibe—atherosclerosis	0.00225	0.0023	CcSEcCtD
Cefuroxime—Pruritus—Lovastatin—atherosclerosis	0.0022	0.00226	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Niacin—atherosclerosis	0.00219	0.00224	CcSEcCtD
Cefuroxime—Nausea—Rosuvastatin—atherosclerosis	0.00218	0.00223	CcSEcCtD
Cefuroxime—Pruritus—Ezetimibe—atherosclerosis	0.00216	0.00221	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00215	0.0022	CcSEcCtD
Cefuroxime—Hypersensitivity—Simvastatin—atherosclerosis	0.00215	0.0022	CcSEcCtD
Cefuroxime—Cefonicid—ALB—atherosclerosis	0.00215	0.0943	CrCbGaD
Cefuroxime—Diarrhoea—Lovastatin—atherosclerosis	0.00213	0.00218	CcSEcCtD
Cefuroxime—Urticaria—Niacin—atherosclerosis	0.00213	0.00218	CcSEcCtD
Cefuroxime—Body temperature increased—Niacin—atherosclerosis	0.00212	0.00216	CcSEcCtD
Cefuroxime—Abdominal pain—Niacin—atherosclerosis	0.00212	0.00216	CcSEcCtD
Cefuroxime—Urticaria—Pravastatin—atherosclerosis	0.00209	0.00214	CcSEcCtD
Cefuroxime—Diarrhoea—Ezetimibe—atherosclerosis	0.00209	0.00214	CcSEcCtD
Cefuroxime—Body temperature increased—Pravastatin—atherosclerosis	0.00208	0.00213	CcSEcCtD
Cefuroxime—Abdominal pain—Pravastatin—atherosclerosis	0.00208	0.00213	CcSEcCtD
Cefuroxime—Pruritus—Simvastatin—atherosclerosis	0.00206	0.00211	CcSEcCtD
Cefuroxime—Dizziness—Lovastatin—atherosclerosis	0.00206	0.00211	CcSEcCtD
Cefuroxime—Dizziness—Ezetimibe—atherosclerosis	0.00202	0.00207	CcSEcCtD
Cefuroxime—Diarrhoea—Simvastatin—atherosclerosis	0.00199	0.00204	CcSEcCtD
Cefuroxime—Vomiting—Lovastatin—atherosclerosis	0.00198	0.00203	CcSEcCtD
Cefuroxime—Hypersensitivity—Niacin—atherosclerosis	0.00197	0.00202	CcSEcCtD
Cefuroxime—Rash—Lovastatin—atherosclerosis	0.00196	0.00201	CcSEcCtD
Cefuroxime—Dermatitis—Lovastatin—atherosclerosis	0.00196	0.00201	CcSEcCtD
Cefuroxime—Headache—Lovastatin—atherosclerosis	0.00195	0.002	CcSEcCtD
Cefuroxime—Vomiting—Ezetimibe—atherosclerosis	0.00194	0.00199	CcSEcCtD
Cefuroxime—Hypersensitivity—Pravastatin—atherosclerosis	0.00194	0.00199	CcSEcCtD
Cefuroxime—Dizziness—Simvastatin—atherosclerosis	0.00193	0.00197	CcSEcCtD
Cefuroxime—Rash—Ezetimibe—atherosclerosis	0.00193	0.00197	CcSEcCtD
Cefuroxime—Dermatitis—Ezetimibe—atherosclerosis	0.00193	0.00197	CcSEcCtD
Cefuroxime—Headache—Ezetimibe—atherosclerosis	0.00191	0.00196	CcSEcCtD
Cefuroxime—Pruritus—Niacin—atherosclerosis	0.00189	0.00194	CcSEcCtD
Cefuroxime—Pruritus—Pravastatin—atherosclerosis	0.00186	0.00191	CcSEcCtD
Cefuroxime—Vomiting—Simvastatin—atherosclerosis	0.00185	0.0019	CcSEcCtD
Cefuroxime—Nausea—Lovastatin—atherosclerosis	0.00185	0.00189	CcSEcCtD
Cefuroxime—Rash—Simvastatin—atherosclerosis	0.00184	0.00188	CcSEcCtD
Cefuroxime—Dermatitis—Simvastatin—atherosclerosis	0.00184	0.00188	CcSEcCtD
Cefuroxime—Diarrhoea—Niacin—atherosclerosis	0.00183	0.00187	CcSEcCtD
Cefuroxime—Headache—Simvastatin—atherosclerosis	0.00183	0.00187	CcSEcCtD
Cefuroxime—Nausea—Ezetimibe—atherosclerosis	0.00182	0.00186	CcSEcCtD
Cefuroxime—Diarrhoea—Pravastatin—atherosclerosis	0.0018	0.00184	CcSEcCtD
Cefuroxime—Dizziness—Niacin—atherosclerosis	0.00177	0.00181	CcSEcCtD
Cefuroxime—Dizziness—Pravastatin—atherosclerosis	0.00174	0.00178	CcSEcCtD
Cefuroxime—Nausea—Simvastatin—atherosclerosis	0.00173	0.00177	CcSEcCtD
Cefuroxime—Vomiting—Niacin—atherosclerosis	0.0017	0.00174	CcSEcCtD
Cefuroxime—Rash—Niacin—atherosclerosis	0.00169	0.00173	CcSEcCtD
Cefuroxime—Dermatitis—Niacin—atherosclerosis	0.00169	0.00173	CcSEcCtD
Cefuroxime—Headache—Niacin—atherosclerosis	0.00168	0.00172	CcSEcCtD
Cefuroxime—Vomiting—Pravastatin—atherosclerosis	0.00168	0.00171	CcSEcCtD
Cefuroxime—Rash—Pravastatin—atherosclerosis	0.00166	0.0017	CcSEcCtD
Cefuroxime—Dermatitis—Pravastatin—atherosclerosis	0.00166	0.0017	CcSEcCtD
Cefuroxime—Headache—Pravastatin—atherosclerosis	0.00165	0.00169	CcSEcCtD
Cefuroxime—Nausea—Niacin—atherosclerosis	0.00159	0.00163	CcSEcCtD
Cefuroxime—Nausea—Pravastatin—atherosclerosis	0.00157	0.0016	CcSEcCtD
Cefuroxime—Cefazolin—ALB—atherosclerosis	0.00104	0.0457	CrCbGaD
Cefuroxime—Ceftriaxone—ALB—atherosclerosis	0.000985	0.0433	CrCbGaD
Cefuroxime—Cefalotin—ALB—atherosclerosis	0.000863	0.0379	CrCbGaD
Cefuroxime—Cephalexin—ALB—atherosclerosis	0.000784	0.0345	CrCbGaD
